In our latest episode, Brad Niles, CEO of ARIZ Precision Medicine, shares his journey from unusual early ventures (like breeding mice and wedding pigeons!) to leading a biotech company working on cutting-edge lung cancer therapies.

Brad opens up about what inspired him to start ARIZ, how personal experiences with cancer shaped his mission, and how his team is developing siRNA-based treatments that target specific genetic drivers like the Prdm2 gene—offering the potential for more precise, less toxic cancer care.

We also talk about:

• What it really takes to build a biotech startup
  
  
• The ups and downs of fundraising and building a strong network
  
  
• How the healthcare landscape is evolving with new regulations, pricing pressures, and shifting cancer trends
  
  

It’s an honest and inspiring look at what drives founders in healthtech—and why staying optimistic and resilient matters more than ever.

🎙️ Tune in now!
https://podcasts.apple.com/us/podcast/why-optimism-and-resilience-are-non-negotiable-in/id1716394190?i=1000713652471 

‍